戻る Agenda
Review on Clinical Development for Drugs/Treatment for COVID19 Pandemic in Globe
Session Chair(s)
Li YAN
Chief Medical Officer of Bro Bioscience, China
The session will review and summarize the best practice and lessons learnt through the major clinical drugs/trials under clinical development for COVID19, the session aims to provide some insights on the potential development model or advanced clinical research design under an outbreak for pandemic infectious diseases